We are pleased to share that Dr. Rainer Lipp, Co-founder of GermanOncology GmbH, Germany, will present his latest research at the International Conference on Cancer Science and Research, happening November 17–19, 2025, in Singapore & Online.
🩺 Presentation Title
📌 Key Highlights from the Study
- Data analyzed from 1,250
patients treated in 25 oncological practices across Germany
(2016–2024).
- Median patient age: 68 years; with 76.8% ≤75
years and 23.2% >75 years.
- Over the last 8 years, a shift
from chemotherapy to immunotherapy combinations was observed.
- ICI (Immune Checkpoint
Inhibitor) use
grew from 33.1% (2016–2019) to 79.9% (2022–2024).
- Traditional chemotherapy
± Bevacizumab declined from 58.4% to 13.6%.
- Patients >75 years
were more frequently treated with ICI monotherapy (30.3%), while
younger patients ≤75 years saw higher use of ICI combinations (59.6%).
- Findings highlight the age-dependent
treatment trends shaping NSCLC standard care.
👨⚕️ About
the Speaker
Dr.
Rainer Lipp is a board-certified hematologist and medical oncologist,
specializing in real-world standard care research in hematology and oncology.
He has held positions at the Lung Clinic Großhansdorf, University
Hospital Münster, and University Hospital Hamburg-Eppendorf.
As
Co-founder of GermanOncology GmbH, he leads a network of 20+ oncology
practices, building a database of 15,000+ longitudinal patient datasets.
Dr. Lipp also manages non-interventional studies for pharmaceutical
companies and supports healthcare consulting in hospital outpatient settings
and reimbursement processes.
📅 Event Information
Event Name: International Conference on
Cancer Science and Research
Dates: November 17–19, 2025
Venue: Village Hotel Changi, Singapore & Online
🌐 Event Website
📝 Register Here
✍️ Submit
Abstract
📧 cancer@mathewsconference.com | 📞 +1 (312)
462-4448 | WhatsApp: +1 (424) 377 0967
Follow us on X for live updates.
#CancerScience2025
#OncologyResearch #LungCancer #NSCLC #Immunotherapy #CancerConference
#MedicalOncology #CancerTreatment #CancerCare #OncologyUpdates